Redeye provides a research update following Penneo’s updated 2022 EBITDA guidance, while preliminary figures indicate an ARR within its guided range. Consequently, we make forecast adjustments to reflect this, leading to a slight upward revision in our valuation.

Read more and download the Research Update.

Follow companies at Redeye to receive the latest equity research within Life Science and Technology.

This is a press release from Redeye - Research Powered Investment Banking. www.redeye.se/

© Modular Finance, source Nordic Press Releases